This company found the miracle cancer cure – then dropped it
Aaron PatrickSenior correspondent
Rick Holliday-Smith, then on the boards of Cochlear and ASX, was speaking at a small Sydney investment conference in late 2019 when he revealed his irritation about investors who refused to stick with promising medical companies.
“Most of the time, we sell at the sizzle stage because people don’t believe enough that the fat is going to follow ... it’s too risky,” he said.
Loading...
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Health & education
Fetching latest articles